Compare KPTI & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KPTI | LSBK |
|---|---|---|
| Founded | 2008 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.6M | 110.0M |
| IPO Year | 2013 | 2025 |
| Metric | KPTI | LSBK |
|---|---|---|
| Price | $7.75 | $15.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.50 | N/A |
| AVG Volume (30 Days) | ★ 624.4K | 10.1K |
| Earning Date | 05-04-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | ★ $146,067,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $46.62 | N/A |
| P/E Ratio | ★ N/A | $22.00 |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $3.51 | $11.50 |
| 52 Week High | $10.99 | $16.40 |
| Indicator | KPTI | LSBK |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 48.92 |
| Support Level | $5.60 | $15.26 |
| Resistance Level | $7.81 | $15.62 |
| Average True Range (ATR) | 0.76 | 0.10 |
| MACD | -0.26 | -0.03 |
| Stochastic Oscillator | 11.08 | 22.64 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.